Clinical Trial Update: Perirenal Adipose Tissue Modification Therapy for Resistant Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating perirenal adipose tissue modification therapy for resistant hypertension is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Resistant Hypertension

Drugs mentioned

• Perirenal Adipose Tissue Modification Therapy

Snippet

Sponsor: Yan Li | Conditions: Resistant Hypertension | Phase 3 | Status: NOT_YET_RECRUITING